Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
Key Details
- 1scSurvival is a machine learning model designed for single-cell resolution analysis in cancer assessment.
- 2Developed with NIH funding by Oregon Health & Science University researchers.
- 3Tested on data from over 150 cancer patients, the tool linked specific tumor and immune cell populations to varying risk and survival outcomes.
- 4The model outperformed traditional methods in predicting outcomes in melanoma and liver cancer.
- 5Research appeared in the journal Cancer Discovery on April 21, 2026.
Why It Matters
Single-cell analytics and AI are at the cutting edge of precision oncology, offering deeper insight into tumor heterogeneity and treatment response. These advances may significantly enhance radiology's role in prognostication and personalized care, especially as multi-modal data integration becomes more common.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.